Pathological complete response (pCR) rates after carboplatin-containing neoadjuvant chemotherapy in patients with germline BRCA (gBRCA) mutation and triple-negative breast cancer (TNBC): Results from GeparSixto.-Reference-Cited by-同舟云学术

Pathological complete response (pCR) rates after carboplatin-containing neoadjuvant chemotherapy in patients with germline BRCA (gBRCA) mutation and triple-negative breast cancer (TNBC): Results from GeparSixto.

Published:2014-05-20 Issue:15_suppl Volume:32 Page:1005-1005
ISSN:0732-183X
Container-title:Journal of Clinical Oncology
language:en
Short-container-title:JCO

Author:

Von Minckwitz Gunter¹,Hahnen Eric²,Fasching Peter A.³,Hauke Jan²,Schneeweiss Andreas⁴,Salat Christoph⁵,Rezai Mahdi⁶,Blohmer Jens U.⁷,Zahm Dirk Michael⁸,Jackisch Christian⁹,Gerber Bernd¹⁰,Klare Peter¹¹,Kummel Sherko¹²,Eidtmann Holger¹³,Paepke Stefan¹⁴,Nekljudova Valentina¹⁵,Loibl Sibylle¹⁶,Untch Michael¹⁷,Schmutzler Rita K.¹⁸,

Affiliation:

1. German Breast Group/University Frankfurt, Neu-Isenburg, Frankfurt, Germany

2. University of Cologne, Cologne, Germany

3. Department of Obstetrics and Gynecology, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg, Comprehensive Cancer Center Erlangen-EMN, Erlangen, Germany

4. University Hospital Heidelberg, Heidelberg, Germany

5. Hematology Oncology Clinic, Munich, Germany

6. Breast Center Duesseldorf, Louisen Hospital, Düsseldorf, Germany

7. Brustzentrum Sankt-Gertrauden-Krankenhaus, Berlin, Germany

8. Frauenklinik Gera, Gera, Germany

9. Sana Kliniken Offenbach, Offenbach, Germany

10. University Rostock, Rostock, Germany

11. Praxisklinik Krebsheilkunde, Berlin, Germany

12. Breast Cancer Centre, Kliniken Essen-Mitte, Evangelische Huyssens-Stiftung, Essen, Germany

13. University Kiel, Kiel, Germany

14. Department of Obstetrics and Gynecology, Klinikum rechts der Isar, Technische Universität München, Munich, Germany

15. German Breast Group, Neu-Isenburg, Germany

16. German Breast Group/Sana Klinikum Offenbach, Neu-Isenburg, Germany

17. Department of Gynecology and Obstetrics and Multidisciplinary Breast Cancer Center, Helios Klinikum Berlin-Buch, Berlin, Germany

18. Center for Familial Breast and Ovarian Cancer and Center of Integrated Oncology, Cologne, Germany

Publisher

American Society of Clinical Oncology (ASCO)

Subject

Cancer Research,Oncology

Link

http://ascopubs.org/doi/pdfdirect/10.1200/jco.2014.32.15_suppl.1005

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Platinum-based chemotherapy for early triple-negative breast cancer;Cochrane Database of Systematic Reviews;2023-09-08

2. New Biomarkers and Treatment Advances in Triple-Negative Breast Cancer;Diagnostics;2023-06-02

3. Comparative analysis of the effectiveness of neoadjuvant systemic therapy and primary surgical treatment of patients with <i>BRCA<i/>-associated triple-negative T1 breast cancer;HERALD of North-Western State Medical University named after I.I. Mechnikov;2023-01-20

4. Hereditary Breast Cancer Non-CDH1 Associated;Hereditary Gastric and Breast Cancer Syndrome;2023

5. Baseline Mutations and Up-Regulation of PI3K-AKT Pathway Serve as Potential Indicators of Lack of Response to Neoadjuvant Chemotherapy in Stage II/III Breast Cancer;Frontiers in Oncology;2022-04-04